Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Verona Pharma plc (VRNA) | 1,115,352 | 1,115,352 | 0 | 32,089 | 51,797 | 18.38% | +19,708 |
| BridgeBio Pharma Inc. (BBIO)(BBIO) | 6,068,125 | 6,068,125 | 0 | 154,494 | 166,509 | 59.08% | +12,015 |
| Poseida Therapeutics Inc. (PSTX) | 1,043,267 | 1,043,267 | 0 | 2,984 | 10,015 | 3.55% | +7,032 |
| Monte Rosa Therapeutics Inc (GLUE)(GLUE) | 1,472,331 | 1,472,331 | 0 | 7,803 | 10,218 | 3.63% | +2,415 |
| Nuvation Bio Inc. (NUVB)(NUVB) | 2,541,009 | 2,541,009 | 0 | 5,819 | 6,759 | 2.40% | +940 |
| OnKure Therapeutics, Inc. (OKUR) | 0 | 88,607 | +88,607 | 0 | 762 | 0.27% | +762 |
| Aclaris Therapeutics Inc (ACRS) | 434,455 | 434,455 | 0 | 500 | 1,077 | 0.38% | +578 |
| Marker Therapeutics, Inc. (MRKR) | 314,286 | 325,370 | +11,084 | 886 | 1,012 | 0.36% | +126 |
| Viracta Therapeutics Inc (VIRX) | 288,571 | 288,571 | 0 | 66 | 46 | 0.02% | -20 |
| Elevation Oncology Inc (ELEV) | 2,834,910 | 2,834,910 | 0 | 1,701 | 1,588 | 0.56% | -113 |
| CalciMedica, Inc. (CALC) | 521,114 | 521,114 | 0 | 2,309 | 1,845 | 0.65% | -464 |
| Reneo Pharmaceuticals Inc (RPHM) | 886,075 | 0 | -886,075 | 1,506 | 0 | — | -1,506 |
| Compass Pathways Plc (CMPS)(CMPS) | 964,500 | 964,500 | 0 | 6,076 | 3,646 | 1.29% | -2,431 |
| Tectonic Therapeutic Inc (TECX) | 84,148 | 0 | -84,148 | 2,550 | 0 | — | -2,550 |
| Bicara Therapeutics Inc. (BCAX) | 568,919 | 568,919 | 0 | 14,490 | 9,911 | 3.52% | -4,580 |
| Biomea Fusion Inc (BMEA) | 798,757 | 798,757 | 0 | 8,067 | 3,099 | 1.10% | -4,968 |
| Syndax Pharmaceuticals, Inc. (SNDX)(SNDX) | 1,025,000 | 1,025,000 | 0 | 19,731 | 13,551 | 4.81% | -6,181 |